Aberrant expression of regulatory cytokine IL-35 in patients with systemic lupus erythematosus

Lupus

Volumn 24, Issue 12, 2015, Pages 1257-1266

  Cai, Z ^a,b   Wong, C K ^a,b   Kam, N W ^b   Dong, J ^a   Jiao, D ^a   Chu, M ^a   Lam, C W K ^c   Tam, L S ^b  

^a CHINESE UNIVERSITY OF HONG KONG   (Hong Kong)

^b CHINESE UNIVERSITY OF HONG KONG   (Hong Kong)

^c MACAU UNIVERSITY OF SCIENCE AND TECHNOLOGY   (Macao)

Author keywords

Cytokines; interleukin 35; regulatory T cells; systemic lupus erythematosus; Systemic Lupus Erythematosus Disease Activity Index

Indexed keywords

CD19 ANTIGEN; GAMMA INTERFERON; GLYCOPROTEIN GP 130; INTERLEUKIN 10; INTERLEUKIN 12 RECEPTOR BETA2; INTERLEUKIN 17; INTERLEUKIN 35; INTERLEUKIN 6; INTERLEUKIN 8; MESSENGER RNA; MONOCYTE CHEMOTACTIC PROTEIN 1; CHEMOKINE; IFNG PROTEIN, HUMAN; IL10 PROTEIN, HUMAN; IL17A PROTEIN, HUMAN; INTERLEUKIN DERIVATIVE; INTERLEUKIN-35, HUMAN;

ADULT; ARTICLE; AUTOIMMUNITY; CD4+ CD25+ T LYMPHOCYTE; CLINICAL ARTICLE; CONTROLLED STUDY; CORRELATIONAL STUDY; ENZYME LINKED IMMUNOSORBENT ASSAY; FEMALE; FLOW CYTOMETRY; GENE EXPRESSION; HUMAN; INVESTIGATIVE PROCEDURES; MALE; PERIPHERAL BLOOD MONONUCLEAR CELL; PRIORITY JOURNAL; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION; SLEDAI; SYSTEMIC LUPUS ERYTHEMATOSUS; BLOOD; CASE CONTROL STUDY; CD4+ T LYMPHOCYTE; METABOLISM; MIDDLE AGED; MONONUCLEAR CELL; REGULATORY T LYMPHOCYTE; YOUNG ADULT;

ADULT; CASE-CONTROL STUDIES; CD4-POSITIVE T-LYMPHOCYTES; CHEMOKINES; CYTOKINE RECEPTOR GP130; FEMALE; FLOW CYTOMETRY; HUMANS; INTERFERON-GAMMA; INTERLEUKIN-10; INTERLEUKIN-17; INTERLEUKIN-6; INTERLEUKINS; LEUKOCYTES, MONONUCLEAR; LUPUS ERYTHEMATOSUS, SYSTEMIC; MALE; MIDDLE AGED; T-LYMPHOCYTES, REGULATORY; YOUNG ADULT;

EID: 84942088086     PISSN: 09612033     EISSN: 14770962     Source Type: Journal    
DOI: 10.1177/0961203315585815     Document Type: Article

References (30)

1. Mok CC, Lau CS,. Pathogenesis of systemic lupus erythematosus. J Clin Pathol 2003; 56: 481-490.
2. Crispín JC, Oukka M, Bayliss G, et al. Expanded double negative T cells in patients with systemic lupus erythematosus produce IL-17 and infiltrate the kidneys. J Immunol 2008; 181: 8761-8766.
3. Collison LW, Vignali DA,. Interleukin-35: Odd one out or part of the family? Immunol Rev 2008; 226: 248-262.
4. Collison LW, Workman CJ, Kuo TT, et al. The inhibitory cytokine IL-35 contributes to regulatory T-cell function. Nature 2007; 450: 566-569.
5. Collison LW, Delgoffe GM, Guy CS, et al. The composition and signaling of the IL-35 receptor are unconventional. Nat Immunol 2012; 13: 290-299.
6. Collison LW, Chaturvedi V, Henderson AL, et al. IL-35-mediated induction of a potent regulatory T cell population. Nat Immunol 2010; 11: 1093-1101.
7. Chaturvedi V, Collison LW, Guy CS, Workman CJ, Vignali DA,. Cutting edge: Human regulatory T cells require IL-35 to mediate suppression and infectious tolerance. J Immunol 2011; 186: 6661-6666.
8. Qiu F, Song L, Yang N, Li X,. Glucocorticoid downregulates expression of IL-12 family cytokines in systemic lupus erythematosus patients. Lupus 2013; 22: 1011-1016.
9. Hochberg MC,. Updating the American College of Rheumatology revised criteria for the classification of systemic lupus erythematosus. Arthritis Rheum 1997; 40: 1725-1725.
10. Bombardier C, Gladman DD, Urowitz MB, Caron D, Chang CH,. Derivation of the SLEDAI. A disease activity index for lupus patients. The Committee on Prognosis Studies in SLE. Arthritis Rheum 1992; 35: 630-640.
11. Gladman DD, Urowitz MB, Goldsmith CH, et al. The reliability of the Systemic Lupus International Collaborating Clinics/American College of Rheumatology Damage Index in patients with systemic lupus erythematosus. Arthritis Rheum 1997; 40: 809-813.
12. Luijten KM, Tekstra J, Bijlsma JW, Bijl M,. The Systemic Lupus Erythematosus Responder Index (SRI); a new SLE disease activity assessment. Autoimmun Rev 2012; 11: 326-329.
13. Tan EM, Cohen AS, Fries JF, et al. The 1982 revised criteria for the classification of systemic lupus erythematosus. Arthritis Rheum 1982; 25: 1271-1277.
14. Schiffenbauer J, Simon LS,. Randomized controlled trials in systemic lupus erythematosus: What has been done and what do we need to do? Lupus 2004; 13: 398-405.
15. Yu SL, Chan PK, Wong CK, et al. Antagonist-mediated down-regulation of toll-like receptors increases the prevalence of human papillomavirus infection in systemic lupus erythematosus. Arthritis Res Ther 2012; 14: R80-R80.
16. + regulatory T-cells in hematologic diseases. Korean J LabMed 2011; 31: 231-237.
17. Bonelli M, von Dalwigk K, Savitskaya A, Smolen JS, Scheinecker C,. Foxp3 expression in CD4+ T cells of patients with systemic lupus erythematosus: A comparative phenotypic analysis. Ann Rheum Dis 2008; 67: 664-671.
18. Tsokos GC, Liossis SN,. Immune cell signaling defects in lupus: Activation, anergy and death. Immunol 1999; 20: 119-124.
19. + T cells in patients with systemic lupus erythematosus. J Immunol 2009; 182: 1689-1695.
20. high T regulatory cell function in patients with active systemic lupus erythematosus. J Immunol 2007; 178: 2579-2588.
21. -T cells in myasthenia gravis. Ann NY Acad Sci 2003; 998: 318-319.
22. + T cells in myasthenia gravis patients with stability and thymectomy. Clin Immunol 2004; 112: 284-289.
23. Salama AD, Chaudhry AN, Holthaus KA, et al. Regulation by CD25+ lymphocytes of autoantigen-specific T-cell responses in Goodpasture’s (anti-GBM) disease. Kidney Int 2003; 64: 1685-1694.
24. + regulatory T cells in patients with multiple sclerosis. J Exp Med 2004; 199: 971-979.
25. Ehrenstein MR, Evans JG, Singh A, et al. Compromised function of regulatory T cells in rheumatoid arthritis and reversal by anti-TNF-alpha therapy. J Exp Med 2004; 200: 277-285.
26. bright regulatory T cells actively regulate inflammation in the joints of patients with the remitting form of juvenile idiopathic arthritis. J Immunol 2004; 172: 6435-6443.
27. + T cells from the target organ of patients with rheumatoid arthritis. Eur J Immunol 2003; 33: 215-223.
28. + regulatory T cells are enriched in inflamed joints of patients with chronic rheumatic disease. Arthritis Res Ther 2004; 6: R335-346.
29. Vignali DA, Collison LW, Workman CJ,. How regulatory T cells work. Nat Rev Immunol 2008; 8: 523-532.
30. + T cells in patients with active systemic lupus erythematosus. Am J Med Sci 2014; 348: 156-161.